Associate Director, Chemical Development
Nuvalent, Inc.(1 day ago)
About this role
Associate Director, Chemical Development at Nuvalent applies chemical engineering and manufacturing expertise to support the design, scale-up, technology transfer, and production lifecycle of small‑molecule drug substances. The role partners with cross‑functional groups including QA, Analytical Sciences, CMC, Supply Chain, and Regulatory to ensure robust manufacturing and continuity of supply at an early‑stage oncology company.
Required Skills
- Process Development
- Scale-Up
- Tech Transfer
- Chemical Engineering
- Process Optimization
- Risk Management
- Statistical Methods
- DOE
- Process Validation
- CDMO Management
+4 more
Qualifications
- Advanced Degree in Chemical Engineering
- Bachelor's Degree in Chemical Engineering
About Nuvalent, Inc.
nuvalent.comNuvalent is a clinical‑stage, Cambridge‑based oncology company that designs precisely targeted small‑molecule therapies using deep chemistry know‑how and structure‑based drug discovery. Its pipeline focuses on selective kinase inhibitors aimed at genetically defined cancers (ALK, ROS1, HER2 and other kinase-driven solid tumors) with the goal of overcoming resistance and improving patient outcomes. Lead programs include NVL‑520, NVL‑655 and NVL‑330, and the company highlights an approach centered on precision medicine, structure‑guided design, and translational development.
Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at Nuvalent, Inc.
Similar Jobs
Director, Process Chemistry
Treeline Biosciences(19 days ago)
Sr. Director, Chemical Development
Acadia Pharmaceuticals Inc.(11 days ago)
Senior Director, CMC Drug Substance Development & Manufacturing
Olema Oncology(1 month ago)
Senior Director, CMC
Amylyx Pharmaceuticals(11 days ago)
Manager/Sr. Manager, Drug Product (Solid-Oral Dose) Commercial Manufacturing Operations
BridgeBio Pharma(8 days ago)
Director, Cell Culture Development
Apogee Therapeutics(25 days ago)